Kiniksa Pharmaceuticals, Ltd.

Bermuda · Reporting entity ID 100000846825

Total reported 2019–2025

$8.39M

#551 of 2,960 reporting companies — 0% of all reported industry payments

$1.38M in general payments across 20,352 records, plus $7.01M in research funding across 5,070 records.

How it breaks down

General payments $1,375,932

Research funding $7,011,923

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.